LS is also termed hereditary nonpolyposis colorectal cancer, and is genetically characterized by the presence of inactivating mutations in MMR genes (MLH1, MSH2, MSH6 and PMS2) and EPCAM [6]. This evidence concerns the gene MRC1 and Leigh syndrome.